|
2025
|
P/S
|
Pharmaceutical preparations for treating cancer and oncological disorders; Pharmaceutical prepara... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular disease... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of cancer and cardiovascular diseas... |
|
|
Invention
|
Solid state forms. The present disclosure provides crystalline and amorphous forms of 6-fluoro-7-... |
|
|
P/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating oncology,... |
|
|
P/S
|
Pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment o... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer and imm... |
|
|
P/S
|
Pharmaceutical preparations, namely, ophthalmic preparations; pharmaceutical preparations for the... |
|
|
P/S
|
providing online information about sustainable manufacturing, development initiatives, and strate... |
|
|
P/S
|
Research and development of pharmaceutical preparations; research and development of pharmaceutic... |
|
|
P/S
|
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
Invention
|
Drug delivery device.
A drug delivery device may include a housing defining a longitudinal axis ... |
|
|
Invention
|
Methods of treating heart failure with cardiac sarcomere activators.
Provided herein are methods... |
|
|
Invention
|
Macrocyclic compounds and methods of use.
The present disclosure provides compounds useful for t... |
|
|
P/S
|
Providing medical information in the field of cardiovascular conditions, diseases, and disorders,... |
|
|
Invention
|
Combinations of a b-raf inhibitor and an anti-egfr antibody for the treatment of cancer.
Provide... |
|
|
P/S
|
Healthcare advisory services; medical advisory services; nutritional advisory services; pharmaceu... |
|
|
Invention
|
Macrocyclic compounds as modulators of kras and uses thereof. Disclosed herein are compounds usef... |
|
|
Invention
|
Spirocyclic compounds as modulators of kras and uses thereof. Disclosed herein are compounds usef... |
|
|
Invention
|
Intensified ultrafiltration/diafiltration processes.
Disclosed herein are ultrafiltration/diafil... |
|
|
Invention
|
Intensified ultrafiltration/diafiltration processes. Disclosed herein are ultrafiltration/diafilt... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation and in... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the treatment of inflammation and i... |
|
|
Invention
|
Method of treating brain metastases in subjects with a dll3-positive cancer. The disclosure provi... |
|
|
Invention
|
Dual selection expression vector systems for multi-chain biologics. Dual selection expression vec... |
|
|
Invention
|
Glucagon receptor agonists and conjugates to glucose-dependent insulinotropic polypeptide antagon... |
|
|
Invention
|
Drug delivery device. A drug delivery device may include a housing having an opening, a drug stor... |
|
|
Invention
|
Glucagon receptor agonists, conjugated to glucose-dependent insulinotropic polypeptide antibodies... |
|
|
Invention
|
Drug delivery device.
A drug delivery device may include a housing having an opening, a drug sto... |
|
|
P/S
|
Research and development of pharmaceutical preparations and biosimilars; research and development... |
|
|
Invention
|
Real-time saving of high-resolution images on commercial automated visual inspection (avi) system... |
|
|
P/S
|
Providing medical information and patient support services, namely, providing medical information... |
|
|
P/S
|
Providing medical information and patient support services,
namely, providing medical informatio... |
|
|
Invention
|
Methods for modulating monoclonal antibody charge variants. The present invention relates to meth... |
|
|
Invention
|
Methods of treating graft versus host disease using il-2 muteins.
Described herein are immunosup... |
|
|
Invention
|
Pharmaceutical formulations of masked antibodies.
The present disclosure is directed to low pH p... |
|
|
Invention
|
Vector engineering strategies to enhance volumetric productivity and decrease impurity formation ... |
|
|
Invention
|
Expression vector systems with two copies of light chain. Disclosed herein are expression systems... |
|
|
Invention
|
Methods for analyzing co-formulated therapeutic proteins. The disclosure provides methods for ana... |
|
|
Invention
|
Method for external sterilization of drug delivery device.
A method of externally sterilizing a ... |
|
|
Invention
|
Antibody constructs for msln and cd3.
The present invention relates to a bispecific antibody con... |
|
|
Invention
|
Low ph pharmaceutical antibody formulation.
The present disclosure describes low pH formulations... |
|
|
Invention
|
Charged depth filtration of antigen-binding proteins.
Methods of producing an aqueous formulatio... |
|
|
Invention
|
Methods and systems for viscosity prediction and protein engineering.
A computer-implemented met... |
|
|
Invention
|
Methods and systems for viscosity prediction and protein engineering. A computer-implemented meth... |
|
|
Invention
|
Treatment of chronic obstructive pulmonary disease with anti-tslp antibody. The present disclosur... |
|
2024
|
Invention
|
Human cd30 ligand antigen binding proteins.
Provided are compositions and methods relating to hu... |
|
|
Invention
|
Integrated bubble trap device and clamp for working heart apparatus. An integrated bubble trap de... |
|
|
P/S
|
Pharmaceutical preparations and substances for use in the
treatment of hematological, immune, au... |
|
|
Invention
|
Sustainable and modular packaging systems for containers for pharmaceutical use.
Systems for pac... |
|
|
Invention
|
Sustainable and modular packaging systems for containers for pharmaceutical use. Systems for pack... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, meta... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disor... |
|
|
Invention
|
Handheld drug delivery device |
|
2023
|
Invention
|
Cannabinoid type 1 receptor binding proteins and uses thereof.
Described herein are anti-CB1 (e.... |
|
|
Invention
|
Anti-pd-1 antibody formulations.
In some aspects, the present disclosure describes stable formul... |
|
|
Invention
|
Heteromultimer binding dll3 and cd3.
The disclosure provides a heteromultimer comprising a first... |
|
|
Invention
|
Processes for making nag-25, a carbohydrate targeting moiety, and its intermediates.
Provided he... |
|
|
Invention
|
Systems and methods for configuring a robot to interface with equipment.
Computer vision techniq... |
|
|
Invention
|
Lyophilization method.
The disclosure provides a method of preparing a lyophilized protein compo... |
|
|
Invention
|
Complement-dependent cytotoxicity methods.
The present invention relates to complement-dependent... |
|
|
Invention
|
Cancer treatments using mta-cooperative prmt5 inhibitors.
Described herein are methods of treati... |
|
|
Invention
|
Treatment of solid tumors.
Methods of treating solid tumors, such as squamous cancer (such as he... |
|
|
Invention
|
Systems and methods for reducing excess resource usage.
Systems, methods, and computer-readable ... |
|
|
Invention
|
Artificial lyophilized product samples for automated visual inspection systems.
Artificial lyo-v... |
|
|
Invention
|
Automated drug filling process.
An automatic drug substance (DS) fill system is provided, compri... |
|
2022
|
Invention
|
Determination of pore size.
Methods of determining a pore size profile of a microfilter are desc... |
|
|
Invention
|
Mageb2 binding constructs.
The present invention relates to binding constructs comprising a doma... |
|
2021
|
Invention
|
Molecules with multiple binding domains.
New formats of multispecific molecules are described, a... |
